NovaDigm Therapeutics
Latest round
- Series B
Last raised
- Oct 2013
Total raised
- $25M
Investors
- 2
About NovaDigm Therapeutics
NovaDigm Therapeutics, Inc.Founded in 2005 in Brookline, US, NovaDigm Therapeutics, Inc. operates as an independent company. NovaDigm has not undergone any noted pivots or changes in business strategy since its inception, nor does it have any subsidiaries or parent companies.NovaDigm specializes in telemedicine solutions that integrate a strong emphasis on longevity and wellness. Their core offerings include personalized health assessments, wellness coaching, and access to GLP-1 medications designed for clients seeking weight management, metabolic support, and blood sugar regulation. Through an online platform, clients can complete quizzes and engage with support teams to tailor their health journeys.NovaDigm's revenue model is structured around subscription services and direct-to-consumer transactions. Clients access treatments and wellness resources through an online platform, which may involve a monthly subscription for health coaching or one-time fees for specific telemedicine consultations and medications. Although specific pricing details for services are undisclosed, the business model emphasizes accessibility through personalized health plans. The company is designing new telemedicine services aimed at improving client outcomes in health management. Furthermore, they seek to penetrate new geographic markets across North America over the coming years, although specific target regions and release dates for new products are not specified.
Who invested in NovaDigm Therapeutics
2 investors across 2 rounds
See all investors in NovaDigm Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NovaDigm Therapeutics
Who invested in NovaDigm Therapeutics?
NovaDigm Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NovaDigm Therapeutics raised?
NovaDigm Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did NovaDigm Therapeutics last raise money?
NovaDigm Therapeutics's most recent round on record is a Series B, in Oct 2013.
What does NovaDigm Therapeutics do?
NovaDigm Therapeutics is a pharmaceuticals company.
Where is NovaDigm Therapeutics headquartered?
NovaDigm Therapeutics is headquartered in Brookline, US.
Which VCs invest in companies like NovaDigm Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at NovaDigm Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like NovaDigm Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.